Drugs  
comments_image Comments

Why is the Obama Administration Suddenly Fixated on Stomping out Medical Pot?

At the same time public support for marijuana legalization reached record highs, Obama shifted from one time medicinal cannabis sympathizer to White House weed-whacker.

Continued from previous page

 
 
Share
 
 
 

-- The IRS has  assessed crippling penalties on tax-paying medical cannabis facilities in California by denying these operations from filing standard expense deductions; 

-- The Department of Treasury has strong-armed local banks and other financial institutions into closing their accounts with medicinal marijuana operators. In Colorado, where the state’s estimated 700 licensed cannabis dispensaries are routinely subjected to state audits, there  no longer remains even a single bank willing to openly do business with med-pot operators. 

-- The Bureau of Alcohol Tobacco and Firearms has  sternly warned firearms dealers not to sell guns to medical cannabis consumers, and stated that patients who otherwise legally possess firearms are in violation of federal law and may face criminal prosecution;

-- In July, the Drug Enforcement Administration  rejected a nine-year-old  administrative petition that called for hearings regarding the federal rescheduling of marijuana for medical use, ignoring extensive scientific evidence of its medical efficacy. “[T]here are no adequate and well-controlled studies proving (marijuana's) efficacy; the drug is not accepted by qualified experts,” the agency alleged. “At this time, the known risks of marijuana use have not been shown to be outweighed by specific benefits in well-controlled clinical trials that scientifically evaluate safety and efficacy.”

-- This fall, the National Institute on Drug Abuse  rejected an FDA-approved protocol to allow for clinical research assessing the use of cannabis to treat post-traumatic stress disorder; a spokesperson for the agency  conceded, “We generally do not fund research focused on the potential beneficial medical effects of marijuana.”

-- The DEA has  reduced the total number of federally qualified investigators licensed to study plant marijuana in humans to 14 nationwide.

Most recently, and perhaps most egregiously, the DEA acknowledged that it was  investigating a Montana state lawmaker for potentially conspiring to violate federal anti-marijuana laws. The lawmaker, Rep. Diane Sands – a Democrat from Missoula, Montana – served as the chairwoman of a 2011 interim legislative committee that sought to enact statewide regulations governing the production and distribution of medical pot, which has been legal in the state since 2004. "Can you say McCarthy?” she told The Missoulian newspaper.  “This sounds like stuff from the House Un-American Activities Committee and Joe McCarthy. So once you talk about medical marijuana in reasonable terms, you're on some sort of list of possible conspirators. … It's ridiculous, of course, but it's also threatening to think that the federal government is willing to use its influence and try to chill discussion about this subject."

* * *

So has the Obama administration collectively lost its mind when it comes to the subject of medical cannabis? That certainly seems to be the case. But the bigger question still remains: Why now?

Speculation among reformers and the general public is widespread. Many activists contend that the administration's about face is due to pressure
from the pharmaceutical industry, which they surmise may be hoping to eliminate competition in the marketplace for their own forthcoming,  soon-to-be FDA-approved cannabis-based drug. Others believe that Obama’s crackdown is a Machiavellian attempt on the part of the President and his advisors to appeal to independent, conservative-leaning swing voters during an election year. Still others argue that the recent attacks have little to do with President Obama at all. Instead, they believe the efforts of the DEA, DOJ, and other federal agencies are being coordinated primarily by drug war hawks within the administration, many of which are  holdovers from the George W. Bush regime, such as DEA administrator Michele Leonhart. Adding weight to this claim are recent statements from US Attorney Andre Birotte, who  acknowledged that the DOJ’s recent activities were led by the federal prosecutors themselves and were not instigated by either President Obama or Attorney General Eric Holder – both of which are engaged in their own personal battles for political survival and, as a result, are unlikely to expend even a shred of political capital to halt the efforts of the administration’s more ardent drug warriors.